<?xml version="1.0" encoding="UTF-8"  standalone="no" ?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2002-01-31" modified="2024-10-02" version="223" xmlns="http://uniprot.org/uniprot">
  <accession>O15455</accession>
  <accession>B2RAI7</accession>
  <accession>B7Z7K0</accession>
  <accession>E6Y0F0</accession>
  <accession>E6Y0F1</accession>
  <accession>E9PGH4</accession>
  <accession>Q4VAL2</accession>
  <accession>Q504W0</accession>
  <name>TLR3_HUMAN</name>
  <protein>
    <recommendedName>
      <fullName evidence="29">Toll-like receptor 3</fullName>
    </recommendedName>
    <cdAntigenName>CD283</cdAntigenName>
  </protein>
  <gene>
    <name evidence="30" type="primary">TLR3</name>
  </gene>
  <organism>
    <name type="scientific">Homo sapiens</name>
    <name type="common">Human</name>
    <dbReference type="NCBI Taxonomy" id="9606"/>
    <lineage>
      <taxon>Eukaryota</taxon>
      <taxon>Metazoa</taxon>
      <taxon>Chordata</taxon>
      <taxon>Craniata</taxon>
      <taxon>Vertebrata</taxon>
      <taxon>Euteleostomi</taxon>
      <taxon>Mammalia</taxon>
      <taxon>Eutheria</taxon>
      <taxon>Euarchontoglires</taxon>
      <taxon>Primates</taxon>
      <taxon>Haplorrhini</taxon>
      <taxon>Catarrhini</taxon>
      <taxon>Hominidae</taxon>
      <taxon>Homo</taxon>
    </lineage>
  </organism>
  <reference key="1">
    <citation type="journal article" date="1998" name="Proc. Natl. Acad. Sci. U.S.A." volume="95" first="588" last="593">
      <title>A family of human receptors structurally related to Drosophila Toll.</title>
      <authorList>
        <person name="Rock F.L."/>
        <person name="Hardiman G."/>
        <person name="Timans J.C."/>
        <person name="Kastelein R.A."/>
        <person name="Bazan J.F."/>
      </authorList>
      <dbReference type="PubMed" id="9435236"/>
      <dbReference type="DOI" id="10.1073/pnas.95.2.588"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
  </reference>
  <reference key="2">
    <citation type="journal article" date="2006" name="J. Mol. Neurosci." volume="29" first="185" last="194">
      <title>The innate immune facet of brain: human neurons express TLR-3 and sense viral dsRNA.</title>
      <authorList>
        <person name="Lafon M."/>
        <person name="Megret F."/>
        <person name="Lafage M."/>
        <person name="Prehaud C."/>
      </authorList>
      <dbReference type="PubMed" id="17085778"/>
      <dbReference type="DOI" id="10.1385/jmn:29:3:185"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
    <scope>TISSUE SPECIFICITY</scope>
    <source>
      <tissue>Neuron</tissue>
    </source>
  </reference>
  <reference key="3">
    <citation type="journal article" date="2008" name="Immunogenetics" volume="60" first="727" last="735">
      <title>Natural selection in the TLR-related genes in the course of primate evolution.</title>
      <authorList>
        <person name="Nakajima T."/>
        <person name="Ohtani H."/>
        <person name="Satta Y."/>
        <person name="Uno Y."/>
        <person name="Akari H."/>
        <person name="Ishida T."/>
        <person name="Kimura A."/>
      </authorList>
      <dbReference type="PubMed" id="18810425"/>
      <dbReference type="DOI" id="10.1007/s00251-008-0332-0"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
  </reference>
  <reference key="4">
    <citation type="submission" date="2006-01" db="EMBL/GenBank/DDBJ databases">
      <title>TLR polymorphism.</title>
      <authorList>
        <person name="Macquin C."/>
        <person name="Bahram S."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
    <scope>VARIANT PHE-412</scope>
  </reference>
  <reference key="5">
    <citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
      <title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
      <authorList>
        <person name="Ota T."/>
        <person name="Suzuki Y."/>
        <person name="Nishikawa T."/>
        <person name="Otsuki T."/>
        <person name="Sugiyama T."/>
        <person name="Irie R."/>
        <person name="Wakamatsu A."/>
        <person name="Hayashi K."/>
        <person name="Sato H."/>
        <person name="Nagai K."/>
        <person name="Kimura K."/>
        <person name="Makita H."/>
        <person name="Sekine M."/>
        <person name="Obayashi M."/>
        <person name="Nishi T."/>
        <person name="Shibahara T."/>
        <person name="Tanaka T."/>
        <person name="Ishii S."/>
        <person name="Yamamoto J."/>
        <person name="Saito K."/>
        <person name="Kawai Y."/>
        <person name="Isono Y."/>
        <person name="Nakamura Y."/>
        <person name="Nagahari K."/>
        <person name="Murakami K."/>
        <person name="Yasuda T."/>
        <person name="Iwayanagi T."/>
        <person name="Wagatsuma M."/>
        <person name="Shiratori A."/>
        <person name="Sudo H."/>
        <person name="Hosoiri T."/>
        <person name="Kaku Y."/>
        <person name="Kodaira H."/>
        <person name="Kondo H."/>
        <person name="Sugawara M."/>
        <person name="Takahashi M."/>
        <person name="Kanda K."/>
        <person name="Yokoi T."/>
        <person name="Furuya T."/>
        <person name="Kikkawa E."/>
        <person name="Omura Y."/>
        <person name="Abe K."/>
        <person name="Kamihara K."/>
        <person name="Katsuta N."/>
        <person name="Sato K."/>
        <person name="Tanikawa M."/>
        <person name="Yamazaki M."/>
        <person name="Ninomiya K."/>
        <person name="Ishibashi T."/>
        <person name="Yamashita H."/>
        <person name="Murakawa K."/>
        <person name="Fujimori K."/>
        <person name="Tanai H."/>
        <person name="Kimata M."/>
        <person name="Watanabe M."/>
        <person name="Hiraoka S."/>
        <person name="Chiba Y."/>
        <person name="Ishida S."/>
        <person name="Ono Y."/>
        <person name="Takiguchi S."/>
        <person name="Watanabe S."/>
        <person name="Yosida M."/>
        <person name="Hotuta T."/>
        <person name="Kusano J."/>
        <person name="Kanehori K."/>
        <person name="Takahashi-Fujii A."/>
        <person name="Hara H."/>
        <person name="Tanase T.-O."/>
        <person name="Nomura Y."/>
        <person name="Togiya S."/>
        <person name="Komai F."/>
        <person name="Hara R."/>
        <person name="Takeuchi K."/>
        <person name="Arita M."/>
        <person name="Imose N."/>
        <person name="Musashino K."/>
        <person name="Yuuki H."/>
        <person name="Oshima A."/>
        <person name="Sasaki N."/>
        <person name="Aotsuka S."/>
        <person name="Yoshikawa Y."/>
        <person name="Matsunawa H."/>
        <person name="Ichihara T."/>
        <person name="Shiohata N."/>
        <person name="Sano S."/>
        <person name="Moriya S."/>
        <person name="Momiyama H."/>
        <person name="Satoh N."/>
        <person name="Takami S."/>
        <person name="Terashima Y."/>
        <person name="Suzuki O."/>
        <person name="Nakagawa S."/>
        <person name="Senoh A."/>
        <person name="Mizoguchi H."/>
        <person name="Goto Y."/>
        <person name="Shimizu F."/>
        <person name="Wakebe H."/>
        <person name="Hishigaki H."/>
        <person name="Watanabe T."/>
        <person name="Sugiyama A."/>
        <person name="Takemoto M."/>
        <person name="Kawakami B."/>
        <person name="Yamazaki M."/>
        <person name="Watanabe K."/>
        <person name="Kumagai A."/>
        <person name="Itakura S."/>
        <person name="Fukuzumi Y."/>
        <person name="Fujimori Y."/>
        <person name="Komiyama M."/>
        <person name="Tashiro H."/>
        <person name="Tanigami A."/>
        <person name="Fujiwara T."/>
        <person name="Ono T."/>
        <person name="Yamada K."/>
        <person name="Fujii Y."/>
        <person name="Ozaki K."/>
        <person name="Hirao M."/>
        <person name="Ohmori Y."/>
        <person name="Kawabata A."/>
        <person name="Hikiji T."/>
        <person name="Kobatake N."/>
        <person name="Inagaki H."/>
        <person name="Ikema Y."/>
        <person name="Okamoto S."/>
        <person name="Okitani R."/>
        <person name="Kawakami T."/>
        <person name="Noguchi S."/>
        <person name="Itoh T."/>
        <person name="Shigeta K."/>
        <person name="Senba T."/>
        <person name="Matsumura K."/>
        <person name="Nakajima Y."/>
        <person name="Mizuno T."/>
        <person name="Morinaga M."/>
        <person name="Sasaki M."/>
        <person name="Togashi T."/>
        <person name="Oyama M."/>
        <person name="Hata H."/>
        <person name="Watanabe M."/>
        <person name="Komatsu T."/>
        <person name="Mizushima-Sugano J."/>
        <person name="Satoh T."/>
        <person name="Shirai Y."/>
        <person name="Takahashi Y."/>
        <person name="Nakagawa K."/>
        <person name="Okumura K."/>
        <person name="Nagase T."/>
        <person name="Nomura N."/>
        <person name="Kikuchi H."/>
        <person name="Masuho Y."/>
        <person name="Yamashita R."/>
        <person name="Nakai K."/>
        <person name="Yada T."/>
        <person name="Nakamura Y."/>
        <person name="Ohara O."/>
        <person name="Isogai T."/>
        <person name="Sugano S."/>
      </authorList>
      <dbReference type="PubMed" id="14702039"/>
      <dbReference type="DOI" id="10.1038/ng1285"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
    <scope>VARIANT PHE-412</scope>
    <source>
      <tissue>Testis</tissue>
      <tissue>Thymus</tissue>
    </source>
  </reference>
  <reference key="6">
    <citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
      <title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
      <authorList>
        <person name="Hillier L.W."/>
        <person name="Graves T.A."/>
        <person name="Fulton R.S."/>
        <person name="Fulton L.A."/>
        <person name="Pepin K.H."/>
        <person name="Minx P."/>
        <person name="Wagner-McPherson C."/>
        <person name="Layman D."/>
        <person name="Wylie K."/>
        <person name="Sekhon M."/>
        <person name="Becker M.C."/>
        <person name="Fewell G.A."/>
        <person name="Delehaunty K.D."/>
        <person name="Miner T.L."/>
        <person name="Nash W.E."/>
        <person name="Kremitzki C."/>
        <person name="Oddy L."/>
        <person name="Du H."/>
        <person name="Sun H."/>
        <person name="Bradshaw-Cordum H."/>
        <person name="Ali J."/>
        <person name="Carter J."/>
        <person name="Cordes M."/>
        <person name="Harris A."/>
        <person name="Isak A."/>
        <person name="van Brunt A."/>
        <person name="Nguyen C."/>
        <person name="Du F."/>
        <person name="Courtney L."/>
        <person name="Kalicki J."/>
        <person name="Ozersky P."/>
        <person name="Abbott S."/>
        <person name="Armstrong J."/>
        <person name="Belter E.A."/>
        <person name="Caruso L."/>
        <person name="Cedroni M."/>
        <person name="Cotton M."/>
        <person name="Davidson T."/>
        <person name="Desai A."/>
        <person name="Elliott G."/>
        <person name="Erb T."/>
        <person name="Fronick C."/>
        <person name="Gaige T."/>
        <person name="Haakenson W."/>
        <person name="Haglund K."/>
        <person name="Holmes A."/>
        <person name="Harkins R."/>
        <person name="Kim K."/>
        <person name="Kruchowski S.S."/>
        <person name="Strong C.M."/>
        <person name="Grewal N."/>
        <person name="Goyea E."/>
        <person name="Hou S."/>
        <person name="Levy A."/>
        <person name="Martinka S."/>
        <person name="Mead K."/>
        <person name="McLellan M.D."/>
        <person name="Meyer R."/>
        <person name="Randall-Maher J."/>
        <person name="Tomlinson C."/>
        <person name="Dauphin-Kohlberg S."/>
        <person name="Kozlowicz-Reilly A."/>
        <person name="Shah N."/>
        <person name="Swearengen-Shahid S."/>
        <person name="Snider J."/>
        <person name="Strong J.T."/>
        <person name="Thompson J."/>
        <person name="Yoakum M."/>
        <person name="Leonard S."/>
        <person name="Pearman C."/>
        <person name="Trani L."/>
        <person name="Radionenko M."/>
        <person name="Waligorski J.E."/>
        <person name="Wang C."/>
        <person name="Rock S.M."/>
        <person name="Tin-Wollam A.-M."/>
        <person name="Maupin R."/>
        <person name="Latreille P."/>
        <person name="Wendl M.C."/>
        <person name="Yang S.-P."/>
        <person name="Pohl C."/>
        <person name="Wallis J.W."/>
        <person name="Spieth J."/>
        <person name="Bieri T.A."/>
        <person name="Berkowicz N."/>
        <person name="Nelson J.O."/>
        <person name="Osborne J."/>
        <person name="Ding L."/>
        <person name="Meyer R."/>
        <person name="Sabo A."/>
        <person name="Shotland Y."/>
        <person name="Sinha P."/>
        <person name="Wohldmann P.E."/>
        <person name="Cook L.L."/>
        <person name="Hickenbotham M.T."/>
        <person name="Eldred J."/>
        <person name="Williams D."/>
        <person name="Jones T.A."/>
        <person name="She X."/>
        <person name="Ciccarelli F.D."/>
        <person name="Izaurralde E."/>
        <person name="Taylor J."/>
        <person name="Schmutz J."/>
        <person name="Myers R.M."/>
        <person name="Cox D.R."/>
        <person name="Huang X."/>
        <person name="McPherson J.D."/>
        <person name="Mardis E.R."/>
        <person name="Clifton S.W."/>
        <person name="Warren W.C."/>
        <person name="Chinwalla A.T."/>
        <person name="Eddy S.R."/>
        <person name="Marra M.A."/>
        <person name="Ovcharenko I."/>
        <person name="Furey T.S."/>
        <person name="Miller W."/>
        <person name="Eichler E.E."/>
        <person name="Bork P."/>
        <person name="Suyama M."/>
        <person name="Torrents D."/>
        <person name="Waterston R.H."/>
        <person name="Wilson R.K."/>
      </authorList>
      <dbReference type="PubMed" id="15815621"/>
      <dbReference type="DOI" id="10.1038/nature03466"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
  </reference>
  <reference key="7">
    <citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
      <authorList>
        <person name="Mural R.J."/>
        <person name="Istrail S."/>
        <person name="Sutton G.G."/>
        <person name="Florea L."/>
        <person name="Halpern A.L."/>
        <person name="Mobarry C.M."/>
        <person name="Lippert R."/>
        <person name="Walenz B."/>
        <person name="Shatkay H."/>
        <person name="Dew I."/>
        <person name="Miller J.R."/>
        <person name="Flanigan M.J."/>
        <person name="Edwards N.J."/>
        <person name="Bolanos R."/>
        <person name="Fasulo D."/>
        <person name="Halldorsson B.V."/>
        <person name="Hannenhalli S."/>
        <person name="Turner R."/>
        <person name="Yooseph S."/>
        <person name="Lu F."/>
        <person name="Nusskern D.R."/>
        <person name="Shue B.C."/>
        <person name="Zheng X.H."/>
        <person name="Zhong F."/>
        <person name="Delcher A.L."/>
        <person name="Huson D.H."/>
        <person name="Kravitz S.A."/>
        <person name="Mouchard L."/>
        <person name="Reinert K."/>
        <person name="Remington K.A."/>
        <person name="Clark A.G."/>
        <person name="Waterman M.S."/>
        <person name="Eichler E.E."/>
        <person name="Adams M.D."/>
        <person name="Hunkapiller M.W."/>
        <person name="Myers E.W."/>
        <person name="Venter J.C."/>
      </authorList>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
  </reference>
  <reference key="8">
    <citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
      <title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
      <authorList>
        <consortium name="The MGC Project Team"/>
      </authorList>
      <dbReference type="PubMed" id="15489334"/>
      <dbReference type="DOI" id="10.1101/gr.2596504"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
    <source>
      <tissue>Placenta</tissue>
    </source>
  </reference>
  <reference key="9">
    <citation type="journal article" date="2004" name="Protein Sci." volume="13" first="2819" last="2824">
      <title>Signal peptide prediction based on analysis of experimentally verified cleavage sites.</title>
      <authorList>
        <person name="Zhang Z."/>
        <person name="Henzel W.J."/>
      </authorList>
      <dbReference type="PubMed" id="15340161"/>
      <dbReference type="DOI" id="10.1110/ps.04682504"/>
    </citation>
    <scope>PROTEIN SEQUENCE OF 24-38</scope>
  </reference>
  <reference key="10">
    <citation type="journal article" date="2002" name="J. Immunol." volume="169" first="6668" last="6672">
      <title>A novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.</title>
      <authorList>
        <person name="Yamamoto M."/>
        <person name="Sato S."/>
        <person name="Mori K."/>
        <person name="Hoshino K."/>
        <person name="Takeuchi O."/>
        <person name="Takeda K."/>
        <person name="Akira S."/>
      </authorList>
      <dbReference type="PubMed" id="12471095"/>
      <dbReference type="DOI" id="10.4049/jimmunol.169.12.6668"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH TICAM1</scope>
  </reference>
  <reference key="11">
    <citation type="journal article" date="2003" name="Nat. Immunol." volume="4" first="161" last="167">
      <title>TICAM-1, an adapter molecule that participates in Toll-like receptor 3 mediated interferon-beta induction.</title>
      <authorList>
        <person name="Oshiumi H."/>
        <person name="Matsumoto M."/>
        <person name="Funami K."/>
        <person name="Akazawa T."/>
        <person name="Seya T."/>
      </authorList>
      <dbReference type="PubMed" id="12539043"/>
      <dbReference type="DOI" id="10.1038/ni886"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>INTERACTION WITH TICAM1</scope>
    <source>
      <tissue>Lung</tissue>
    </source>
  </reference>
  <reference key="12">
    <citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="38133" last="38145">
      <title>Recognition of double-stranded RNA by human toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH.</title>
      <authorList>
        <person name="de Bouteiller O."/>
        <person name="Merck E."/>
        <person name="Hasan U.A."/>
        <person name="Hubac S."/>
        <person name="Benguigui B."/>
        <person name="Trinchieri G."/>
        <person name="Bates E.E."/>
        <person name="Caux C."/>
      </authorList>
      <dbReference type="PubMed" id="16144834"/>
      <dbReference type="DOI" id="10.1074/jbc.m507163200"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>SUBUNIT</scope>
    <scope>MUTAGENESIS OF CYS-95; CYS-122; ASN-196 AND ASN-247</scope>
  </reference>
  <reference key="13">
    <citation type="journal article" date="2006" name="EMBO J." volume="25" first="3335" last="3346">
      <title>Toll-like receptor 3 associates with c-Src tyrosine kinase on endosomes to initiate antiviral signaling.</title>
      <authorList>
        <person name="Johnsen I.B."/>
        <person name="Nguyen T.T."/>
        <person name="Ringdal M."/>
        <person name="Tryggestad A.M."/>
        <person name="Bakke O."/>
        <person name="Lien E."/>
        <person name="Espevik T."/>
        <person name="Anthonsen M.W."/>
      </authorList>
      <dbReference type="PubMed" id="16858407"/>
      <dbReference type="DOI" id="10.1038/sj.emboj.7601222"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>INTERACTION WITH SRC</scope>
  </reference>
  <reference key="14">
    <citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="8792" last="8797">
      <title>The dsRNA binding site of human Toll-like receptor 3.</title>
      <authorList>
        <person name="Bell J.K."/>
        <person name="Askins J."/>
        <person name="Hall P.R."/>
        <person name="Davies D.R."/>
        <person name="Segal D.M."/>
      </authorList>
      <dbReference type="PubMed" id="16720699"/>
      <dbReference type="DOI" id="10.1073/pnas.0603245103"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>MUTAGENESIS OF HIS-539 AND ASN-541</scope>
  </reference>
  <reference key="15">
    <citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="3423" last="3427">
      <title>Two tyrosine residues of Toll-like receptor 3 trigger different steps of NF-kappa B activation.</title>
      <authorList>
        <person name="Sarkar S.N."/>
        <person name="Elco C.P."/>
        <person name="Peters K.L."/>
        <person name="Chattopadhyay S."/>
        <person name="Sen G.C."/>
      </authorList>
      <dbReference type="PubMed" id="17178723"/>
      <dbReference type="DOI" id="10.1074/jbc.c600226200"/>
    </citation>
    <scope>PHOSPHORYLATION AT TYR-759 AND TYR-858</scope>
    <scope>FUNCTION</scope>
    <scope>MUTAGENESIS OF TYR-759</scope>
  </reference>
  <reference key="16">
    <citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="258" last="263">
      <title>The TLR3 signaling complex forms by cooperative receptor dimerization.</title>
      <authorList>
        <person name="Leonard J.N."/>
        <person name="Ghirlando R."/>
        <person name="Askins J."/>
        <person name="Bell J.K."/>
        <person name="Margulies D.H."/>
        <person name="Davies D.R."/>
        <person name="Segal D.M."/>
      </authorList>
      <dbReference type="PubMed" id="18172197"/>
      <dbReference type="DOI" id="10.1073/pnas.0710779105"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>DOUBLE-STRANDED RNA-BINDING</scope>
    <scope>HOMODIMERIZATION</scope>
  </reference>
  <reference key="17">
    <citation type="journal article" date="2009" name="J. Proteome Res." volume="8" first="651" last="661">
      <title>Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.</title>
      <authorList>
        <person name="Chen R."/>
        <person name="Jiang X."/>
        <person name="Sun D."/>
        <person name="Han G."/>
        <person name="Wang F."/>
        <person name="Ye M."/>
        <person name="Wang L."/>
        <person name="Zou H."/>
      </authorList>
      <dbReference type="PubMed" id="19159218"/>
      <dbReference type="DOI" id="10.1021/pr8008012"/>
    </citation>
    <scope>GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-52 AND ASN-57</scope>
    <source>
      <tissue>Liver</tissue>
    </source>
  </reference>
  <reference key="18">
    <citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="9053" last="9058">
      <title>Cleavage of Toll-like receptor 3 by cathepsins B and H is essential for signaling.</title>
      <authorList>
        <person name="Garcia-Cattaneo A."/>
        <person name="Gobert F.X."/>
        <person name="Muller M."/>
        <person name="Toscano F."/>
        <person name="Flores M."/>
        <person name="Lescure A."/>
        <person name="Del Nery E."/>
        <person name="Benaroch P."/>
      </authorList>
      <dbReference type="PubMed" id="22611194"/>
      <dbReference type="DOI" id="10.1073/pnas.1115091109"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>PROTEOLYTIC PROCESSING</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>INTERACTION WITH UNC93B1</scope>
  </reference>
  <reference key="19">
    <citation type="journal article" date="2015" name="EMBO Rep." volume="16" first="447" last="455">
      <title>WDFY1 mediates TLR3/4 signaling by recruiting TRIF.</title>
      <authorList>
        <person name="Hu Y.H."/>
        <person name="Zhang Y."/>
        <person name="Jiang L.Q."/>
        <person name="Wang S."/>
        <person name="Lei C.Q."/>
        <person name="Sun M.S."/>
        <person name="Shu H.B."/>
        <person name="Liu Y."/>
      </authorList>
      <dbReference type="PubMed" id="25736436"/>
      <dbReference type="DOI" id="10.15252/embr.201439637"/>
    </citation>
    <scope>INTERACTION WITH WDFY1 AND TICAM1</scope>
    <scope>SUBCELLULAR LOCATION</scope>
    <scope>MUTAGENESIS OF TYR-759 AND TYR-858</scope>
  </reference>
  <reference key="20">
    <citation type="journal article" date="2020" name="Proc. Natl. Acad. Sci. U.S.A." volume="117" first="23707" last="23716">
      <title>Ubiquitination of TLR3 by TRIM3 signals its ESCRT-mediated trafficking to the endolysosomes for innate antiviral response.</title>
      <authorList>
        <person name="Li W.W."/>
        <person name="Nie Y."/>
        <person name="Yang Y."/>
        <person name="Ran Y."/>
        <person name="Luo W.W."/>
        <person name="Xiong M.G."/>
        <person name="Wang S.Y."/>
        <person name="Xu Z.S."/>
        <person name="Wang Y.Y."/>
      </authorList>
      <dbReference type="PubMed" id="32878999"/>
      <dbReference type="DOI" id="10.1073/pnas.2002472117"/>
    </citation>
    <scope>UBIQUITINATION AT LYS-831 BY TRIM3</scope>
    <scope>MUTAGENESIS OF LYS-831</scope>
  </reference>
  <reference key="21">
    <citation type="journal article" date="2020" name="Cell. Mol. Immunol." volume="17" first="865" last="874">
      <title>E3 ubiquitin ligase RNF170 inhibits innate immune responses by targeting and degrading TLR3 in murine cells.</title>
      <authorList>
        <person name="Song X."/>
        <person name="Liu S."/>
        <person name="Wang W."/>
        <person name="Ma Z."/>
        <person name="Cao X."/>
        <person name="Jiang M."/>
      </authorList>
      <dbReference type="PubMed" id="31076723"/>
      <dbReference type="DOI" id="10.1038/s41423-019-0236-y"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>UBIQUITINATION BY RNF170</scope>
  </reference>
  <reference key="22">
    <citation type="journal article" date="2023" name="J. Exp. Med." volume="220">
      <title>The Src-ZNRF1 axis controls TLR3 trafficking and interferon responses to limit lung barrier damage.</title>
      <authorList>
        <person name="Lin Y.S."/>
        <person name="Chang Y.C."/>
        <person name="Chao T.L."/>
        <person name="Tsai Y.M."/>
        <person name="Jhuang S.J."/>
        <person name="Ho Y.H."/>
        <person name="Lai T.Y."/>
        <person name="Liu Y.L."/>
        <person name="Chen C.Y."/>
        <person name="Tsai C.Y."/>
        <person name="Hsueh Y.P."/>
        <person name="Chang S.Y."/>
        <person name="Chuang T.H."/>
        <person name="Lee C.Y."/>
        <person name="Hsu L.C."/>
      </authorList>
      <dbReference type="PubMed" id="37158982"/>
      <dbReference type="DOI" id="10.1084/jem.20220727"/>
    </citation>
    <scope>UBIQUITINATION AT LYS-812</scope>
    <scope>MUTAGENESIS OF LYS-812</scope>
  </reference>
  <reference key="23">
    <citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="10976" last="10980">
      <title>The molecular structure of the Toll-like receptor 3 ligand-binding domain.</title>
      <authorList>
        <person name="Bell J.K."/>
        <person name="Botos I."/>
        <person name="Hall P.R."/>
        <person name="Askins J."/>
        <person name="Shiloach J."/>
        <person name="Segal D.M."/>
        <person name="Davies D.R."/>
      </authorList>
      <dbReference type="PubMed" id="16043704"/>
      <dbReference type="DOI" id="10.1073/pnas.0505077102"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 22-703</scope>
    <scope>FUNCTION</scope>
    <scope>DISULFIDE BONDS</scope>
    <scope>SUBUNIT</scope>
    <scope>GLYCOSYLATION AT ASN-52; ASN-70; ASN-196; ASN-252; ASN-265; ASN-275; ASN-291; ASN-398; ASN-413; ASN-507 AND ASN-636</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
  </reference>
  <reference key="24">
    <citation type="journal article" date="2005" name="Science" volume="309" first="581" last="585">
      <title>Crystal structure of human toll-like receptor 3 (TLR3) ectodomain.</title>
      <authorList>
        <person name="Choe J."/>
        <person name="Kelker M.S."/>
        <person name="Wilson I.A."/>
      </authorList>
      <dbReference type="PubMed" id="15961631"/>
      <dbReference type="DOI" id="10.1126/science.1115253"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 27-700</scope>
    <scope>DISULFIDE BONDS</scope>
    <scope>GLYCOSYLATION AT ASN-124; ASN-252; ASN-275; ASN-291; ASN-398; ASN-413 AND ASN-507</scope>
  </reference>
  <reference key="25">
    <citation type="journal article" date="2012" name="J. Mol. Biol." volume="421" first="112" last="124">
      <title>Lateral clustering of TLR3:dsRNA signaling units revealed by TLR3ecd:3Fabs quaternary structure.</title>
      <authorList>
        <person name="Luo J."/>
        <person name="Obmolova G."/>
        <person name="Malia T.J."/>
        <person name="Wu S.J."/>
        <person name="Duffy K.E."/>
        <person name="Marion J.D."/>
        <person name="Bell J.K."/>
        <person name="Ge P."/>
        <person name="Zhou Z.H."/>
        <person name="Teplyakov A."/>
        <person name="Zhao Y."/>
        <person name="Lamb R.J."/>
        <person name="Jordan J.L."/>
        <person name="San Mateo L.R."/>
        <person name="Sweet R.W."/>
        <person name="Gilliland G.L."/>
      </authorList>
      <dbReference type="PubMed" id="22579623"/>
      <dbReference type="DOI" id="10.1016/j.jmb.2012.05.006"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (3.52 ANGSTROMS) OF 22-702 IN COMPLEX WITH ANTIBODY</scope>
    <scope>DISULFIDE BONDS</scope>
    <scope>SUBUNIT</scope>
    <scope>DS-RNA BINDING REGIONS</scope>
    <scope>GLYCOSYLATION AT ASN-52; ASN-70; ASN-124; ASN-247; ASN-252; ASN-265; ASN-275; ASN-291; ASN-398; ASN-413 AND ASN-507</scope>
  </reference>
  <reference evidence="31" key="26">
    <citation type="journal article" date="2021" name="Nat. Struct. Mol. Biol." volume="28" first="173" last="180">
      <title>Cryo-EM structures of Toll-like receptors in complex with UNC93B1.</title>
      <authorList>
        <person name="Ishida H."/>
        <person name="Asami J."/>
        <person name="Zhang Z."/>
        <person name="Nishizawa T."/>
        <person name="Shigematsu H."/>
        <person name="Ohto U."/>
        <person name="Shimizu T."/>
      </authorList>
      <dbReference type="PubMed" id="33432245"/>
      <dbReference type="DOI" id="10.1038/s41594-020-00542-w"/>
    </citation>
    <scope>STRUCTURE BY ELECTRON MICROSCOPY (3.40 ANGSTROMS) IN COMPLEX WITH UNC93B1</scope>
    <scope>INTERACTION WITH UNC93B1</scope>
  </reference>
  <reference key="27">
    <citation type="journal article" date="2007" name="Science" volume="317" first="1522" last="1527">
      <title>TLR3 deficiency in patients with herpes simplex encephalitis.</title>
      <authorList>
        <person name="Zhang S.-Y."/>
        <person name="Jouanguy E."/>
        <person name="Ugolini S."/>
        <person name="Smahi A."/>
        <person name="Elain G."/>
        <person name="Romero P."/>
        <person name="Segal D."/>
        <person name="Sancho-Shimizu V."/>
        <person name="Lorenzo L."/>
        <person name="Puel A."/>
        <person name="Picard C."/>
        <person name="Chapgier A."/>
        <person name="Plancoulaine S."/>
        <person name="Titeux M."/>
        <person name="Cognet C."/>
        <person name="von Bernuth H."/>
        <person name="Ku C.-L."/>
        <person name="Casrouge A."/>
        <person name="Zhang X.-X."/>
        <person name="Barreiro L."/>
        <person name="Leonard J."/>
        <person name="Hamilton C."/>
        <person name="Lebon P."/>
        <person name="Heron B."/>
        <person name="Vallee L."/>
        <person name="Quintana-Murci L."/>
        <person name="Hovnanian A."/>
        <person name="Rozenberg F."/>
        <person name="Vivier E."/>
        <person name="Geissmann F."/>
        <person name="Tardieu M."/>
        <person name="Abel L."/>
        <person name="Casanova J.-L."/>
      </authorList>
      <dbReference type="PubMed" id="17872438"/>
      <dbReference type="DOI" id="10.1126/science.1139522"/>
    </citation>
    <scope>VARIANT IMD83 SER-554</scope>
  </reference>
  <reference key="28">
    <citation type="journal article" date="2008" name="N. Engl. J. Med." volume="359" first="1456" last="1463">
      <title>Toll-like receptor 3 and geographic atrophy in age-related macular degeneration.</title>
      <authorList>
        <person name="Yang Z."/>
        <person name="Stratton C."/>
        <person name="Francis P.J."/>
        <person name="Kleinman M.E."/>
        <person name="Tan P.L."/>
        <person name="Gibbs D."/>
        <person name="Tong Z."/>
        <person name="Chen H."/>
        <person name="Constantine R."/>
        <person name="Yang X."/>
        <person name="Chen Y."/>
        <person name="Zeng J."/>
        <person name="Davey L."/>
        <person name="Ma X."/>
        <person name="Hau V.S."/>
        <person name="Wang C."/>
        <person name="Harmon J."/>
        <person name="Buehler J."/>
        <person name="Pearson E."/>
        <person name="Patel S."/>
        <person name="Kaminoh Y."/>
        <person name="Watkins S."/>
        <person name="Luo L."/>
        <person name="Zabriskie N.A."/>
        <person name="Bernstein P.S."/>
        <person name="Cho W."/>
        <person name="Schwager A."/>
        <person name="Hinton D.R."/>
        <person name="Klein M.L."/>
        <person name="Hamon S.C."/>
        <person name="Simmons E."/>
        <person name="Yu B."/>
        <person name="Campochiaro B."/>
        <person name="Sunness J.S."/>
        <person name="Campochiaro P."/>
        <person name="Jorde L."/>
        <person name="Parmigiani G."/>
        <person name="Zack D.J."/>
        <person name="Katsanis N."/>
        <person name="Ambati J."/>
        <person name="Zhang K."/>
      </authorList>
      <dbReference type="PubMed" id="18753640"/>
      <dbReference type="DOI" id="10.1056/nejmoa0802437"/>
    </citation>
    <scope>VARIANT PHE-412</scope>
  </reference>
  <reference key="29">
    <citation type="journal article" date="2008" name="N. Engl. J. Med." volume="359" first="1859" last="1859">
      <authorList>
        <person name="Yang Z."/>
        <person name="Stratton C."/>
        <person name="Francis P.J."/>
        <person name="Kleinman M.E."/>
        <person name="Tan P.L."/>
        <person name="Gibbs D."/>
        <person name="Tong Z."/>
        <person name="Chen H."/>
        <person name="Constantine R."/>
        <person name="Yang X."/>
        <person name="Chen Y."/>
        <person name="Zeng J."/>
        <person name="Davey L."/>
        <person name="Ma X."/>
        <person name="Hau V.S."/>
        <person name="Wang C."/>
        <person name="Harmon J."/>
        <person name="Buehler J."/>
        <person name="Pearson E."/>
        <person name="Patel S."/>
        <person name="Kaminoh Y."/>
        <person name="Watkins S."/>
        <person name="Luo L."/>
        <person name="Zabriskie N.A."/>
        <person name="Bernstein P.S."/>
        <person name="Cho W."/>
        <person name="Schwager A."/>
        <person name="Hinton D.R."/>
        <person name="Klein M.L."/>
        <person name="Hamon S.C."/>
        <person name="Simmons E."/>
        <person name="Yu B."/>
        <person name="Campochiaro B."/>
        <person name="Sunness J.S."/>
        <person name="Campochiaro P."/>
        <person name="Jorde L."/>
        <person name="Parmigiani G."/>
        <person name="Zack D.J."/>
        <person name="Katsanis N."/>
        <person name="Ambati J."/>
        <person name="Zhang K."/>
      </authorList>
    </citation>
    <scope>ERRATUM OF PUBMED:18753640</scope>
  </reference>
  <reference key="30">
    <citation type="journal article" date="2012" name="J. Immunol." volume="188" first="818" last="823">
      <title>A common polymorphism in TLR3 confers natural resistance to HIV-1 infection.</title>
      <authorList>
        <person name="Sironi M."/>
        <person name="Biasin M."/>
        <person name="Cagliani R."/>
        <person name="Forni D."/>
        <person name="De Luca M."/>
        <person name="Saulle I."/>
        <person name="Lo Caputo S."/>
        <person name="Mazzotta F."/>
        <person name="Macias J."/>
        <person name="Pineda J.A."/>
        <person name="Caruz A."/>
        <person name="Clerici M."/>
      </authorList>
      <dbReference type="PubMed" id="22174453"/>
      <dbReference type="DOI" id="10.4049/jimmunol.1102179"/>
    </citation>
    <scope>VARIANT PHE-412</scope>
  </reference>
  <reference key="31">
    <citation type="journal article" date="2020" name="Science" volume="370">
      <title>Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.</title>
      <authorList>
        <consortium name="COVID-STORM Clinicians"/>
        <consortium name="COVID Clinicians"/>
        <consortium name="Imagine COVID Group"/>
        <consortium name="French COVID Cohort Study Group"/>
        <consortium name="CoV-Contact Cohort"/>
        <consortium name="Amsterdam UMC Covid-19 Biobank"/>
        <consortium name="COVID Human Genetic Effort"/>
        <consortium name="NIAID-USUHS/TAGC COVID Immunity Group"/>
        <person name="Zhang Q."/>
        <person name="Bastard P."/>
        <person name="Liu Z."/>
        <person name="Le Pen J."/>
        <person name="Moncada-Velez M."/>
        <person name="Chen J."/>
        <person name="Ogishi M."/>
        <person name="Sabli I.K.D."/>
        <person name="Hodeib S."/>
        <person name="Korol C."/>
        <person name="Rosain J."/>
        <person name="Bilguvar K."/>
        <person name="Ye J."/>
        <person name="Bolze A."/>
        <person name="Bigio B."/>
        <person name="Yang R."/>
        <person name="Arias A.A."/>
        <person name="Zhou Q."/>
        <person name="Zhang Y."/>
        <person name="Onodi F."/>
        <person name="Korniotis S."/>
        <person name="Karpf L."/>
        <person name="Philippot Q."/>
        <person name="Chbihi M."/>
        <person name="Bonnet-Madin L."/>
        <person name="Dorgham K."/>
        <person name="Smith N."/>
        <person name="Schneider W.M."/>
        <person name="Razooky B.S."/>
        <person name="Hoffmann H.H."/>
        <person name="Michailidis E."/>
        <person name="Moens L."/>
        <person name="Han J.E."/>
        <person name="Lorenzo L."/>
        <person name="Bizien L."/>
        <person name="Meade P."/>
        <person name="Neehus A.L."/>
        <person name="Ugurbil A.C."/>
        <person name="Corneau A."/>
        <person name="Kerner G."/>
        <person name="Zhang P."/>
        <person name="Rapaport F."/>
        <person name="Seeleuthner Y."/>
        <person name="Manry J."/>
        <person name="Masson C."/>
        <person name="Schmitt Y."/>
        <person name="Schlueter A."/>
        <person name="Le Voyer T."/>
        <person name="Khan T."/>
        <person name="Li J."/>
        <person name="Fellay J."/>
        <person name="Roussel L."/>
        <person name="Shahrooei M."/>
        <person name="Alosaimi M.F."/>
        <person name="Mansouri D."/>
        <person name="Al-Saud H."/>
        <person name="Al-Mulla F."/>
        <person name="Almourfi F."/>
        <person name="Al-Muhsen S.Z."/>
        <person name="Alsohime F."/>
        <person name="Al Turki S."/>
        <person name="Hasanato R."/>
        <person name="van de Beek D."/>
        <person name="Biondi A."/>
        <person name="Bettini L.R."/>
        <person name="D'Angio' M."/>
        <person name="Bonfanti P."/>
        <person name="Imberti L."/>
        <person name="Sottini A."/>
        <person name="Paghera S."/>
        <person name="Quiros-Roldan E."/>
        <person name="Rossi C."/>
        <person name="Oler A.J."/>
        <person name="Tompkins M.F."/>
        <person name="Alba C."/>
        <person name="Vandernoot I."/>
        <person name="Goffard J.C."/>
        <person name="Smits G."/>
        <person name="Migeotte I."/>
        <person name="Haerynck F."/>
        <person name="Soler-Palacin P."/>
        <person name="Martin-Nalda A."/>
        <person name="Colobran R."/>
        <person name="Morange P.E."/>
        <person name="Keles S."/>
        <person name="Coelkesen F."/>
        <person name="Ozcelik T."/>
        <person name="Yasar K.K."/>
        <person name="Senoglu S."/>
        <person name="Karabela S.N."/>
        <person name="Rodriguez-Gallego C."/>
        <person name="Novelli G."/>
        <person name="Hraiech S."/>
        <person name="Tandjaoui-Lambiotte Y."/>
        <person name="Duval X."/>
        <person name="Laouenan C."/>
        <person name="Snow A.L."/>
        <person name="Dalgard C.L."/>
        <person name="Milner J.D."/>
        <person name="Vinh D.C."/>
        <person name="Mogensen T.H."/>
        <person name="Marr N."/>
        <person name="Spaan A.N."/>
        <person name="Boisson B."/>
        <person name="Boisson-Dupuis S."/>
        <person name="Bustamante J."/>
        <person name="Puel A."/>
        <person name="Ciancanelli M.J."/>
        <person name="Meyts I."/>
        <person name="Maniatis T."/>
        <person name="Soumelis V."/>
        <person name="Amara A."/>
        <person name="Nussenzweig M."/>
        <person name="Garcia-Sastre A."/>
        <person name="Krammer F."/>
        <person name="Pujol A."/>
        <person name="Duffy D."/>
        <person name="Lifton R.P."/>
        <person name="Zhang S.Y."/>
        <person name="Gorochov G."/>
        <person name="Beziat V."/>
        <person name="Jouanguy E."/>
        <person name="Sancho-Shimizu V."/>
        <person name="Rice C.M."/>
        <person name="Abel L."/>
        <person name="Notarangelo L.D."/>
        <person name="Cobat A."/>
        <person name="Su H.C."/>
        <person name="Casanova J.L."/>
      </authorList>
      <dbReference type="PubMed" id="32972995"/>
      <dbReference type="DOI" id="10.1126/science.abd4570"/>
    </citation>
    <scope>VARIANTS PRO-134; GLY-251; SER-554; LEU-732; 746-GLU--HIS-904 DEL; 769-TRP--HIS-904 DEL; GLN-867 AND VAL-870</scope>
    <scope>CHARACTERIZATION OF VARIANTS PRO-134; GLY-251; SER-554; LEU-732; 746-GLU--HIS-904 DEL; 769-TRP--HIS-904 DEL; GLN-867 AND VAL-870</scope>
  </reference>
  <comment type="function">
    <text evidence="3 4 8 9 10 11 13 15 20">Key component of innate and adaptive immunity. TLRs (Toll-like receptors) control host immune response against pathogens through recognition of molecular patterns specific to microorganisms. TLR3 is a nucleotide-sensing TLR which is activated by double-stranded RNA, a sign of viral infection. Acts via the adapter TRIF/TICAM1, leading to NF-kappa-B activation, IRF3 nuclear translocation, cytokine secretion and the inflammatory response.</text>
  </comment>
  <comment type="subunit">
    <text evidence="3 4 8 9 11 19 20 21 22 25">Monomer and homodimer; dimerization is triggered by ligand-binding, the signaling unit is composed of one ds-RNA of around 40 bp and two TLR3 molecules, and lateral clustering of signaling units along the length of the ds-RNA ligand is required for TLR3 signal transduction. Interacts (via transmembrane domain) with UNC93B1; the interaction is required for transport from the ER to the endosomes (PubMed:33432245). Interacts with SRC; upon binding of double-stranded RNA. Interacts with TICAM1 (via the TIR domain) in response to poly(I:C) and this interaction is enhanced in the presence of WDFY1 (PubMed:25736436). The tyrosine-phosphorylated form (via TIR domain) interacts with WDFY1 (via WD repeat 2) in response to poly(I:C) (PubMed:25736436).</text>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-6116630">
      <id>O15455</id>
    </interactant>
    <interactant intactId="EBI-79464">
      <id>P27986</id>
      <label>PIK3R1</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-6116630">
      <id>O15455</id>
    </interactant>
    <interactant intactId="EBI-6116630">
      <id>O15455</id>
      <label>TLR3</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>5</experiments>
  </comment>
  <comment type="subcellular location">
    <subcellularLocation>
      <location>Endoplasmic reticulum membrane</location>
      <topology>Single-pass type I membrane protein</topology>
    </subcellularLocation>
    <subcellularLocation>
      <location>Endosome membrane</location>
    </subcellularLocation>
    <subcellularLocation>
      <location evidence="21">Early endosome</location>
    </subcellularLocation>
  </comment>
  <comment type="alternative products">
    <event type="alternative splicing"/>
    <isoform>
      <id>O15455-1</id>
      <name>1</name>
      <sequence type="displayed"/>
    </isoform>
    <isoform>
      <id>O15455-2</id>
      <name>2</name>
      <sequence type="described" ref="VSP_054188"/>
    </isoform>
  </comment>
  <comment type="tissue specificity">
    <text evidence="12">Expressed at high level in placenta and pancreas. Also detected in CD11c+ immature dendritic cells. Only expressed in dendritic cells and not in other leukocytes, including monocyte precursors. TLR3 is the TLR that is expressed most strongly in the brain, especially in astrocytes, glia, and neurons.</text>
  </comment>
  <comment type="domain">
    <text>ds-RNA binding is mediated by LRR 1 to 3, and LRR 17 to 18.</text>
  </comment>
  <comment type="PTM">
    <text evidence="7 8 17 19">Heavily N-glycosylated, except on that part of the surface of the ectodomain that is involved in ligand binding.</text>
  </comment>
  <comment type="PTM">
    <text evidence="20">TLR3 signaling requires a proteolytic cleavage mediated by cathepsins CTSB and CTSH, the cleavage occurs between amino acids 252 and 346. The cleaved form of TLR3 is the predominant form found in endosomes.</text>
  </comment>
  <comment type="PTM">
    <text evidence="22 23 26">Ubiquitinated by TRIM3; leading to recognition and sorting of polyubiquitinated TLR3 by the ESCRT complexes (PubMed:32878999). Ubiquitinated by ZNRF1 via 'Lys-63'-linked ubiquitin chains; leading to TLR3 lysosomal trafficking and degradation (PubMed:37158982). Ubiquitinated by RNF170 at Lys-765 via 'Lys-48'-linked ubiquitin chains; leading to TLR3 proteasomal degradation (PubMed:31076723).</text>
  </comment>
  <comment type="polymorphism">
    <text>The Phe-412 allele (dbSNP:rs3775291) occurs with a frequency of 30% in populations with European and Asian ancestry, and confers some natural resistance to HIV-1 infection.</text>
  </comment>
  <comment type="disease" evidence="14">
    <disease id="DI-02371">
      <name>Immunodeficiency 83, susceptibility to viral infections</name>
      <acronym>IMD83</acronym>
      <description>An immunologic disorder characterized by increased susceptibility to severe viral infections, including herpes simplex virus (HSV), varicella zoster virus (VZV), influenza A virus (IAV), hantavirus, and possibly respiratory syncytial virus (RSV). IMD83 clinical manifestations include acute infection-induced encephalitis and pneumonitis. The susceptibility to encephalitis or pneumonitis appears to result from impaired TLR3-dependent interferon production by nonhematopoietic cells that reside within the central nervous system or lung epithelial cells. IMD83 transmission pattern is consistent with autosomal dominant or autosomal recessive inheritance with incomplete penetrance.</description>
      <dbReference type="MIM" id="613002"/>
    </disease>
    <text>The disease is caused by variants affecting the gene represented in this entry.</text>
  </comment>
  <comment type="similarity">
    <text evidence="29">Belongs to the Toll-like receptor family.</text>
  </comment>
  <comment type="online information" name="TLR3base">
    <link uri="https://databases.lovd.nl/shared/genes/TLR3"/>
    <text>TLR3 mutation db</text>
  </comment>
  <dbReference type="EMBL" id="U88879">
    <property type="protein sequence ID" value="AAC34134.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="DQ445682">
    <property type="protein sequence ID" value="ABE01399.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AB445631">
    <property type="protein sequence ID" value="BAG55028.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="DQ360814">
    <property type="protein sequence ID" value="ABC86908.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="DQ360815">
    <property type="protein sequence ID" value="ABC86909.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="DQ360816">
    <property type="protein sequence ID" value="ABC86910.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AK302143">
    <property type="protein sequence ID" value="BAH13636.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AK314208">
    <property type="protein sequence ID" value="BAG36884.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AC104070">
    <property type="status" value="NOT_ANNOTATED_CDS"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="CH471056">
    <property type="protein sequence ID" value="EAX04628.1"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC094737">
    <property type="protein sequence ID" value="AAH94737.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC096333">
    <property type="protein sequence ID" value="AAH96333.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC096334">
    <property type="protein sequence ID" value="AAH96334.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC096335">
    <property type="protein sequence ID" value="AAH96335.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS3846.1">
    <molecule id="O15455-1"/>
  </dbReference>
  <dbReference type="RefSeq" id="NP_003256.1">
    <molecule id="O15455-1"/>
    <property type="nucleotide sequence ID" value="NM_003265.2"/>
  </dbReference>
  <dbReference type="RefSeq" id="XP_016864066.1">
    <property type="nucleotide sequence ID" value="XM_017008577.1"/>
  </dbReference>
  <dbReference type="PDB" id="1ZIW">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.10 A"/>
    <property type="chains" value="A=27-700"/>
  </dbReference>
  <dbReference type="PDB" id="2A0Z">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.40 A"/>
    <property type="chains" value="A=22-703"/>
  </dbReference>
  <dbReference type="PDB" id="2MK9">
    <property type="method" value="NMR"/>
    <property type="chains" value="A/B=698-730"/>
  </dbReference>
  <dbReference type="PDB" id="2MKA">
    <property type="method" value="NMR"/>
    <property type="chains" value="A/B/C=698-730"/>
  </dbReference>
  <dbReference type="PDB" id="3ULU">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.52 A"/>
    <property type="chains" value="A=22-702"/>
  </dbReference>
  <dbReference type="PDB" id="3ULV">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.52 A"/>
    <property type="chains" value="A=22-702"/>
  </dbReference>
  <dbReference type="PDB" id="5GS0">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="3.27 A"/>
    <property type="chains" value="A/B=27-697"/>
  </dbReference>
  <dbReference type="PDB" id="7C76">
    <property type="method" value="EM"/>
    <property type="resolution" value="3.40 A"/>
    <property type="chains" value="A=1-904"/>
  </dbReference>
  <dbReference type="PDB" id="7WV3">
    <property type="method" value="EM"/>
    <property type="resolution" value="2.26 A"/>
    <property type="chains" value="A/B/C/D=24-904"/>
  </dbReference>
  <dbReference type="PDB" id="7WV4">
    <property type="method" value="EM"/>
    <property type="resolution" value="3.35 A"/>
    <property type="chains" value="A/B/C/D=27-697"/>
  </dbReference>
  <dbReference type="PDB" id="7WV5">
    <property type="method" value="EM"/>
    <property type="resolution" value="3.10 A"/>
    <property type="chains" value="A/B=27-697"/>
  </dbReference>
  <dbReference type="PDB" id="7WVE">
    <property type="method" value="EM"/>
    <property type="resolution" value="3.11 A"/>
    <property type="chains" value="A/B=27-697"/>
  </dbReference>
  <dbReference type="PDB" id="7WVF">
    <property type="method" value="EM"/>
    <property type="resolution" value="3.91 A"/>
    <property type="chains" value="A/B=27-697"/>
  </dbReference>
  <dbReference type="PDB" id="7WVJ">
    <property type="method" value="EM"/>
    <property type="resolution" value="3.26 A"/>
    <property type="chains" value="A/B=27-697"/>
  </dbReference>
  <dbReference type="PDB" id="8AR1">
    <property type="method" value="NMR"/>
    <property type="chains" value="A=698-746"/>
  </dbReference>
  <dbReference type="PDBsum" id="1ZIW"/>
  <dbReference type="PDBsum" id="2A0Z"/>
  <dbReference type="PDBsum" id="2MK9"/>
  <dbReference type="PDBsum" id="2MKA"/>
  <dbReference type="PDBsum" id="3ULU"/>
  <dbReference type="PDBsum" id="3ULV"/>
  <dbReference type="PDBsum" id="5GS0"/>
  <dbReference type="PDBsum" id="7C76"/>
  <dbReference type="PDBsum" id="7WV3"/>
  <dbReference type="PDBsum" id="7WV4"/>
  <dbReference type="PDBsum" id="7WV5"/>
  <dbReference type="PDBsum" id="7WVE"/>
  <dbReference type="PDBsum" id="7WVF"/>
  <dbReference type="PDBsum" id="7WVJ"/>
  <dbReference type="PDBsum" id="8AR1"/>
  <dbReference type="AlphaFoldDB" id="O15455"/>
  <dbReference type="BMRB" id="O15455"/>
  <dbReference type="EMDB" id="EMD-30293"/>
  <dbReference type="EMDB" id="EMD-32844"/>
  <dbReference type="EMDB" id="EMD-32845"/>
  <dbReference type="EMDB" id="EMD-32846"/>
  <dbReference type="EMDB" id="EMD-32851"/>
  <dbReference type="EMDB" id="EMD-32852"/>
  <dbReference type="EMDB" id="EMD-32853"/>
  <dbReference type="SMR" id="O15455"/>
  <dbReference type="BioGRID" id="112953">
    <property type="interactions" value="48"/>
  </dbReference>
  <dbReference type="DIP" id="DIP-29660N"/>
  <dbReference type="IntAct" id="O15455">
    <property type="interactions" value="21"/>
  </dbReference>
  <dbReference type="MINT" id="O15455"/>
  <dbReference type="STRING" id="9606.ENSP00000296795"/>
  <dbReference type="BindingDB" id="O15455"/>
  <dbReference type="ChEMBL" id="CHEMBL1075113"/>
  <dbReference type="TCDB" id="8.A.43.1.35">
    <property type="family name" value="the neat-domain containing methaemoglobin heme sequestration (n-mhs) family"/>
  </dbReference>
  <dbReference type="GlyCosmos" id="O15455">
    <property type="glycosylation" value="15 sites, No reported glycans"/>
  </dbReference>
  <dbReference type="GlyGen" id="O15455">
    <property type="glycosylation" value="17 sites, 1 O-linked glycan (1 site)"/>
  </dbReference>
  <dbReference type="iPTMnet" id="O15455"/>
  <dbReference type="PhosphoSitePlus" id="O15455"/>
  <dbReference type="BioMuta" id="TLR3"/>
  <dbReference type="jPOST" id="O15455"/>
  <dbReference type="MassIVE" id="O15455"/>
  <dbReference type="PaxDb" id="9606-ENSP00000296795"/>
  <dbReference type="PeptideAtlas" id="O15455"/>
  <dbReference type="ProteomicsDB" id="20320"/>
  <dbReference type="ProteomicsDB" id="48678">
    <molecule id="O15455-1"/>
  </dbReference>
  <dbReference type="Pumba" id="O15455"/>
  <dbReference type="ABCD" id="O15455">
    <property type="antibodies" value="13 sequenced antibodies"/>
  </dbReference>
  <dbReference type="Antibodypedia" id="17502">
    <property type="antibodies" value="1214 antibodies from 47 providers"/>
  </dbReference>
  <dbReference type="DNASU" id="7098"/>
  <dbReference type="Ensembl" id="ENST00000296795.8">
    <molecule id="O15455-1"/>
    <property type="protein sequence ID" value="ENSP00000296795.3"/>
    <property type="gene ID" value="ENSG00000164342.14"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000504367.1">
    <molecule id="O15455-2"/>
    <property type="protein sequence ID" value="ENSP00000423684.1"/>
    <property type="gene ID" value="ENSG00000164342.14"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000508051.2">
    <molecule id="O15455-2"/>
    <property type="protein sequence ID" value="ENSP00000513677.1"/>
    <property type="gene ID" value="ENSG00000164342.14"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000512264.1">
    <molecule id="O15455-2"/>
    <property type="protein sequence ID" value="ENSP00000513668.1"/>
    <property type="gene ID" value="ENSG00000164342.14"/>
  </dbReference>
  <dbReference type="Ensembl" id="ENST00000698354.1">
    <molecule id="O15455-2"/>
    <property type="protein sequence ID" value="ENSP00000513676.1"/>
    <property type="gene ID" value="ENSG00000164342.14"/>
  </dbReference>
  <dbReference type="GeneID" id="7098"/>
  <dbReference type="KEGG" id="hsa:7098"/>
  <dbReference type="MANE-Select" id="ENST00000296795.8">
    <property type="protein sequence ID" value="ENSP00000296795.3"/>
    <property type="RefSeq nucleotide sequence ID" value="NM_003265.3"/>
    <property type="RefSeq protein sequence ID" value="NP_003256.1"/>
  </dbReference>
  <dbReference type="UCSC" id="uc003iyq.4">
    <molecule id="O15455-1"/>
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="AGR" id="HGNC:11849"/>
  <dbReference type="CTD" id="7098"/>
  <dbReference type="DisGeNET" id="7098"/>
  <dbReference type="GeneCards" id="TLR3"/>
  <dbReference type="HGNC" id="HGNC:11849">
    <property type="gene designation" value="TLR3"/>
  </dbReference>
  <dbReference type="HPA" id="ENSG00000164342">
    <property type="expression patterns" value="Low tissue specificity"/>
  </dbReference>
  <dbReference type="MalaCards" id="TLR3"/>
  <dbReference type="MIM" id="603029">
    <property type="type" value="gene"/>
  </dbReference>
  <dbReference type="MIM" id="613002">
    <property type="type" value="phenotype"/>
  </dbReference>
  <dbReference type="neXtProt" id="NX_O15455"/>
  <dbReference type="OpenTargets" id="ENSG00000164342"/>
  <dbReference type="Orphanet" id="1930">
    <property type="disease" value="Herpes simplex virus encephalitis"/>
  </dbReference>
  <dbReference type="PharmGKB" id="PA36551"/>
  <dbReference type="VEuPathDB" id="HostDB:ENSG00000164342"/>
  <dbReference type="eggNOG" id="KOG4641">
    <property type="taxonomic scope" value="Eukaryota"/>
  </dbReference>
  <dbReference type="GeneTree" id="ENSGT00940000159678"/>
  <dbReference type="HOGENOM" id="CLU_006000_4_1_1"/>
  <dbReference type="InParanoid" id="O15455"/>
  <dbReference type="OMA" id="PYIYFWG"/>
  <dbReference type="OrthoDB" id="3428126at2759"/>
  <dbReference type="PhylomeDB" id="O15455"/>
  <dbReference type="TreeFam" id="TF325595"/>
  <dbReference type="PathwayCommons" id="O15455"/>
  <dbReference type="Reactome" id="R-HSA-1679131">
    <property type="pathway name" value="Trafficking and processing of endosomal TLR"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-168164">
    <property type="pathway name" value="Toll Like Receptor 3 (TLR3) Cascade"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-168927">
    <property type="pathway name" value="TICAM1, RIP1-mediated IKK complex recruitment"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-1810476">
    <property type="pathway name" value="RIP-mediated NFkB activation via ZBP1"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-5602410">
    <property type="pathway name" value="TLR3 deficiency - HSE"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-5602415">
    <property type="pathway name" value="UNC93B1 deficiency - HSE"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-5602566">
    <property type="pathway name" value="TICAM1 deficiency - HSE"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-5602571">
    <property type="pathway name" value="TRAF3 deficiency - HSE"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-9013957">
    <property type="pathway name" value="TLR3-mediated TICAM1-dependent programmed cell death"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-9013973">
    <property type="pathway name" value="TICAM1-dependent activation of IRF3/IRF7"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-9014325">
    <property type="pathway name" value="TICAM1,TRAF6-dependent induction of TAK1 complex"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-9828211">
    <property type="pathway name" value="Regulation of TBK1, IKKEpsilon-mediated activation of IRF3, IRF7 upon TLR3 ligation"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-9833110">
    <property type="pathway name" value="RSV-host interactions"/>
  </dbReference>
  <dbReference type="SignaLink" id="O15455"/>
  <dbReference type="SIGNOR" id="O15455"/>
  <dbReference type="BioGRID-ORCS" id="7098">
    <property type="hits" value="12 hits in 1155 CRISPR screens"/>
  </dbReference>
  <dbReference type="ChiTaRS" id="TLR3">
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="EvolutionaryTrace" id="O15455"/>
  <dbReference type="GeneWiki" id="TLR_3"/>
  <dbReference type="GenomeRNAi" id="7098"/>
  <dbReference type="Pharos" id="O15455">
    <property type="development level" value="Tbio"/>
  </dbReference>
  <dbReference type="PRO" id="PR:O15455"/>
  <dbReference type="Proteomes" id="UP000005640">
    <property type="component" value="Chromosome 4"/>
  </dbReference>
  <dbReference type="RNAct" id="O15455">
    <property type="molecule type" value="protein"/>
  </dbReference>
  <dbReference type="Bgee" id="ENSG00000164342">
    <property type="expression patterns" value="Expressed in jejunal mucosa and 169 other cell types or tissues"/>
  </dbReference>
  <dbReference type="ExpressionAtlas" id="O15455">
    <property type="expression patterns" value="baseline and differential"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005737">
    <property type="term" value="C:cytoplasm"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005769">
    <property type="term" value="C:early endosome"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProt"/>
  </dbReference>
  <dbReference type="GO" id="GO:0036020">
    <property type="term" value="C:endolysosome membrane"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="Reactome"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005789">
    <property type="term" value="C:endoplasmic reticulum membrane"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="Reactome"/>
  </dbReference>
  <dbReference type="GO" id="GO:0010008">
    <property type="term" value="C:endosome membrane"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="UniProt"/>
  </dbReference>
  <dbReference type="GO" id="GO:0031012">
    <property type="term" value="C:extracellular matrix"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005615">
    <property type="term" value="C:extracellular space"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0000139">
    <property type="term" value="C:Golgi membrane"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="Reactome"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005765">
    <property type="term" value="C:lysosomal membrane"/>
    <property type="evidence" value="ECO:0007005"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0016020">
    <property type="term" value="C:membrane"/>
    <property type="evidence" value="ECO:0000303"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005886">
    <property type="term" value="C:plasma membrane"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="ProtInc"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003725">
    <property type="term" value="F:double-stranded RNA binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0042802">
    <property type="term" value="F:identical protein binding"/>
    <property type="evidence" value="ECO:0000353"/>
    <property type="project" value="IntAct"/>
  </dbReference>
  <dbReference type="GO" id="GO:0038187">
    <property type="term" value="F:pattern recognition receptor activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0038023">
    <property type="term" value="F:signaling receptor activity"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0004888">
    <property type="term" value="F:transmembrane signaling receptor activity"/>
    <property type="evidence" value="ECO:0000303"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0007250">
    <property type="term" value="P:activation of NF-kappaB-inducing kinase activity"/>
    <property type="evidence" value="ECO:0000303"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0071360">
    <property type="term" value="P:cellular response to exogenous dsRNA"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0035458">
    <property type="term" value="P:cellular response to interferon-beta"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0071260">
    <property type="term" value="P:cellular response to mechanical stimulus"/>
    <property type="evidence" value="ECO:0000270"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0071346">
    <property type="term" value="P:cellular response to type II interferon"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0098586">
    <property type="term" value="P:cellular response to virus"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0071466">
    <property type="term" value="P:cellular response to xenobiotic stimulus"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0042742">
    <property type="term" value="P:defense response to bacterium"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="ProtInc"/>
  </dbReference>
  <dbReference type="GO" id="GO:0051607">
    <property type="term" value="P:defense response to virus"/>
    <property type="evidence" value="ECO:0000270"/>
    <property type="project" value="ARUK-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0009597">
    <property type="term" value="P:detection of virus"/>
    <property type="evidence" value="ECO:0000303"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0097191">
    <property type="term" value="P:extrinsic apoptotic signaling pathway"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006972">
    <property type="term" value="P:hyperosmotic response"/>
    <property type="evidence" value="ECO:0000303"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0007252">
    <property type="term" value="P:I-kappaB phosphorylation"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0090594">
    <property type="term" value="P:inflammatory response to wounding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProt"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045087">
    <property type="term" value="P:innate immune response"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0007254">
    <property type="term" value="P:JNK cascade"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0008584">
    <property type="term" value="P:male gonad development"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0001774">
    <property type="term" value="P:microglial cell activation"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0097527">
    <property type="term" value="P:necroptotic signaling pathway"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045671">
    <property type="term" value="P:negative regulation of osteoclast differentiation"/>
    <property type="evidence" value="ECO:0000303"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045766">
    <property type="term" value="P:positive regulation of angiogenesis"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0043065">
    <property type="term" value="P:positive regulation of apoptotic process"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0043123">
    <property type="term" value="P:positive regulation of canonical NF-kappaB signal transduction"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0032722">
    <property type="term" value="P:positive regulation of chemokine production"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:1900017">
    <property type="term" value="P:positive regulation of cytokine production involved in inflammatory response"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0010628">
    <property type="term" value="P:positive regulation of gene expression"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0050729">
    <property type="term" value="P:positive regulation of inflammatory response"/>
    <property type="evidence" value="ECO:0000305"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0032727">
    <property type="term" value="P:positive regulation of interferon-alpha production"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0032728">
    <property type="term" value="P:positive regulation of interferon-beta production"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0032735">
    <property type="term" value="P:positive regulation of interleukin-12 production"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0032755">
    <property type="term" value="P:positive regulation of interleukin-6 production"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0032757">
    <property type="term" value="P:positive regulation of interleukin-8 production"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0046330">
    <property type="term" value="P:positive regulation of JNK cascade"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProt"/>
  </dbReference>
  <dbReference type="GO" id="GO:0060907">
    <property type="term" value="P:positive regulation of macrophage cytokine production"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:1901224">
    <property type="term" value="P:positive regulation of non-canonical NF-kappaB signal transduction"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045944">
    <property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0032760">
    <property type="term" value="P:positive regulation of tumor necrosis factor production"/>
    <property type="evidence" value="ECO:0000250"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0032729">
    <property type="term" value="P:positive regulation of type II interferon production"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0034346">
    <property type="term" value="P:positive regulation of type III interferon production"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0002730">
    <property type="term" value="P:regulation of dendritic cell cytokine production"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="GO" id="GO:0043331">
    <property type="term" value="P:response to dsRNA"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0043330">
    <property type="term" value="P:response to exogenous dsRNA"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="MGI"/>
  </dbReference>
  <dbReference type="GO" id="GO:0007165">
    <property type="term" value="P:signal transduction"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="ProtInc"/>
  </dbReference>
  <dbReference type="GO" id="GO:0034138">
    <property type="term" value="P:toll-like receptor 3 signaling pathway"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="BHF-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0002224">
    <property type="term" value="P:toll-like receptor signaling pathway"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProt"/>
  </dbReference>
  <dbReference type="GO" id="GO:0034343">
    <property type="term" value="P:type III interferon production"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="Ensembl"/>
  </dbReference>
  <dbReference type="Gene3D" id="3.80.10.10">
    <property type="entry name" value="Ribonuclease Inhibitor"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Gene3D" id="3.40.50.10140">
    <property type="entry name" value="Toll/interleukin-1 receptor homology (TIR) domain"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR000483">
    <property type="entry name" value="Cys-rich_flank_reg_C"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR001611">
    <property type="entry name" value="Leu-rich_rpt"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR003591">
    <property type="entry name" value="Leu-rich_rpt_typical-subtyp"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR032675">
    <property type="entry name" value="LRR_dom_sf"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR000157">
    <property type="entry name" value="TIR_dom"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR041015">
    <property type="entry name" value="TLR3_TMD"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR017241">
    <property type="entry name" value="Toll-like_receptor"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR035897">
    <property type="entry name" value="Toll_tir_struct_dom_sf"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR24365">
    <property type="entry name" value="TOLL-LIKE RECEPTOR"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR24365:SF524">
    <property type="entry name" value="TOLL-LIKE RECEPTOR 3"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF13516">
    <property type="entry name" value="LRR_6"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF13855">
    <property type="entry name" value="LRR_8"/>
    <property type="match status" value="6"/>
  </dbReference>
  <dbReference type="Pfam" id="PF01582">
    <property type="entry name" value="TIR"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF17968">
    <property type="entry name" value="Tlr3_TMD"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PRINTS" id="PR00019">
    <property type="entry name" value="LEURICHRPT"/>
  </dbReference>
  <dbReference type="SMART" id="SM00365">
    <property type="entry name" value="LRR_SD22"/>
    <property type="match status" value="8"/>
  </dbReference>
  <dbReference type="SMART" id="SM00369">
    <property type="entry name" value="LRR_TYP"/>
    <property type="match status" value="16"/>
  </dbReference>
  <dbReference type="SMART" id="SM00082">
    <property type="entry name" value="LRRCT"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SMART" id="SM00255">
    <property type="entry name" value="TIR"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF52058">
    <property type="entry name" value="L domain-like"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF52200">
    <property type="entry name" value="Toll/Interleukin receptor TIR domain"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS51450">
    <property type="entry name" value="LRR"/>
    <property type="match status" value="19"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS50104">
    <property type="entry name" value="TIR"/>
    <property type="match status" value="1"/>
  </dbReference>
  <proteinExistence type="evidence at protein level"/>
  <keyword id="KW-0002">3D-structure</keyword>
  <keyword id="KW-0025">Alternative splicing</keyword>
  <keyword id="KW-0903">Direct protein sequencing</keyword>
  <keyword id="KW-0225">Disease variant</keyword>
  <keyword id="KW-1015">Disulfide bond</keyword>
  <keyword id="KW-0256">Endoplasmic reticulum</keyword>
  <keyword id="KW-0967">Endosome</keyword>
  <keyword id="KW-0325">Glycoprotein</keyword>
  <keyword id="KW-0391">Immunity</keyword>
  <keyword id="KW-0395">Inflammatory response</keyword>
  <keyword id="KW-0399">Innate immunity</keyword>
  <keyword id="KW-1017">Isopeptide bond</keyword>
  <keyword id="KW-0433">Leucine-rich repeat</keyword>
  <keyword id="KW-0472">Membrane</keyword>
  <keyword id="KW-0597">Phosphoprotein</keyword>
  <keyword id="KW-1267">Proteomics identification</keyword>
  <keyword id="KW-0675">Receptor</keyword>
  <keyword id="KW-1185">Reference proteome</keyword>
  <keyword id="KW-0677">Repeat</keyword>
  <keyword id="KW-0694">RNA-binding</keyword>
  <keyword id="KW-0732">Signal</keyword>
  <keyword id="KW-0812">Transmembrane</keyword>
  <keyword id="KW-1133">Transmembrane helix</keyword>
  <keyword id="KW-0832">Ubl conjugation</keyword>
  <feature type="signal peptide" evidence="6">
    <location>
      <begin position="1"/>
      <end position="23"/>
    </location>
  </feature>
  <feature type="chain" id="PRO_0000034715" description="Toll-like receptor 3">
    <location>
      <begin position="24"/>
      <end position="904"/>
    </location>
  </feature>
  <feature type="topological domain" description="Lumenal" evidence="1">
    <location>
      <begin position="24"/>
      <end position="704"/>
    </location>
  </feature>
  <feature type="transmembrane region" description="Helical" evidence="1">
    <location>
      <begin position="705"/>
      <end position="725"/>
    </location>
  </feature>
  <feature type="topological domain" description="Cytoplasmic" evidence="1">
    <location>
      <begin position="726"/>
      <end position="904"/>
    </location>
  </feature>
  <feature type="domain" description="LRRNT">
    <location>
      <begin position="24"/>
      <end position="51"/>
    </location>
  </feature>
  <feature type="repeat" description="LRR 1">
    <location>
      <begin position="52"/>
      <end position="73"/>
    </location>
  </feature>
  <feature type="repeat" description="LRR 2">
    <location>
      <begin position="76"/>
      <end position="97"/>
    </location>
  </feature>
  <feature type="repeat" description="LRR 3">
    <location>
      <begin position="100"/>
      <end position="121"/>
    </location>
  </feature>
  <feature type="repeat" description="LRR 4">
    <location>
      <begin position="124"/>
      <end position="145"/>
    </location>
  </feature>
  <feature type="repeat" description="LRR 5">
    <location>
      <begin position="148"/>
      <end position="168"/>
    </location>
  </feature>
  <feature type="repeat" description="LRR 6">
    <location>
      <begin position="172"/>
      <end position="193"/>
    </location>
  </feature>
  <feature type="repeat" description="LRR 7">
    <location>
      <begin position="198"/>
      <end position="219"/>
    </location>
  </feature>
  <feature type="repeat" description="LRR 8">
    <location>
      <begin position="222"/>
      <end position="244"/>
    </location>
  </feature>
  <feature type="repeat" description="LRR 9">
    <location>
      <begin position="249"/>
      <end position="270"/>
    </location>
  </feature>
  <feature type="repeat" description="LRR 10">
    <location>
      <begin position="275"/>
      <end position="296"/>
    </location>
  </feature>
  <feature type="repeat" description="LRR 11">
    <location>
      <begin position="299"/>
      <end position="320"/>
    </location>
  </feature>
  <feature type="repeat" description="LRR 12">
    <location>
      <begin position="323"/>
      <end position="344"/>
    </location>
  </feature>
  <feature type="repeat" description="LRR 13">
    <location>
      <begin position="356"/>
      <end position="377"/>
    </location>
  </feature>
  <feature type="repeat" description="LRR 14">
    <location>
      <begin position="380"/>
      <end position="400"/>
    </location>
  </feature>
  <feature type="repeat" description="LRR 15">
    <location>
      <begin position="408"/>
      <end position="429"/>
    </location>
  </feature>
  <feature type="repeat" description="LRR 16">
    <location>
      <begin position="432"/>
      <end position="454"/>
    </location>
  </feature>
  <feature type="repeat" description="LRR 17">
    <location>
      <begin position="465"/>
      <end position="486"/>
    </location>
  </feature>
  <feature type="repeat" description="LRR 18">
    <location>
      <begin position="507"/>
      <end position="528"/>
    </location>
  </feature>
  <feature type="repeat" description="LRR 19">
    <location>
      <begin position="531"/>
      <end position="552"/>
    </location>
  </feature>
  <feature type="repeat" description="LRR 20">
    <location>
      <begin position="563"/>
      <end position="584"/>
    </location>
  </feature>
  <feature type="repeat" description="LRR 21">
    <location>
      <begin position="587"/>
      <end position="608"/>
    </location>
  </feature>
  <feature type="repeat" description="LRR 22">
    <location>
      <begin position="611"/>
      <end position="632"/>
    </location>
  </feature>
  <feature type="domain" description="LRRCT">
    <location>
      <begin position="645"/>
      <end position="698"/>
    </location>
  </feature>
  <feature type="domain" description="TIR" evidence="2">
    <location>
      <begin position="754"/>
      <end position="897"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphotyrosine" evidence="13">
    <location>
      <position position="759"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphotyrosine" evidence="13">
    <location>
      <position position="858"/>
    </location>
  </feature>
  <feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8 17 19">
    <location>
      <position position="52"/>
    </location>
  </feature>
  <feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="17">
    <location>
      <position position="57"/>
    </location>
  </feature>
  <feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8 19">
    <location>
      <position position="70"/>
    </location>
  </feature>
  <feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7 19">
    <location>
      <position position="124"/>
    </location>
  </feature>
  <feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
    <location>
      <position position="196"/>
    </location>
  </feature>
  <feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="19">
    <location>
      <position position="247"/>
    </location>
  </feature>
  <feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7 8 19">
    <location>
      <position position="252"/>
    </location>
  </feature>
  <feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8 19">
    <location>
      <position position="265"/>
    </location>
  </feature>
  <feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7 8 19">
    <location>
      <position position="275"/>
    </location>
  </feature>
  <feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7 8 19">
    <location>
      <position position="291"/>
    </location>
  </feature>
  <feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7 8 19">
    <location>
      <position position="398"/>
    </location>
  </feature>
  <feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7 8 19">
    <location>
      <position position="413"/>
    </location>
  </feature>
  <feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="7 8 19">
    <location>
      <position position="507"/>
    </location>
  </feature>
  <feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="8">
    <location>
      <position position="636"/>
    </location>
  </feature>
  <feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1">
    <location>
      <position position="662"/>
    </location>
  </feature>
  <feature type="disulfide bond">
    <location>
      <begin position="28"/>
      <end position="37"/>
    </location>
  </feature>
  <feature type="disulfide bond">
    <location>
      <begin position="95"/>
      <end position="122"/>
    </location>
  </feature>
  <feature type="disulfide bond">
    <location>
      <begin position="649"/>
      <end position="677"/>
    </location>
  </feature>
  <feature type="disulfide bond">
    <location>
      <begin position="651"/>
      <end position="696"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="26">
    <location>
      <position position="765"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="26">
    <location>
      <position position="812"/>
    </location>
  </feature>
  <feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="23">
    <location>
      <position position="831"/>
    </location>
  </feature>
  <feature type="splice variant" id="VSP_054188" description="In isoform 2." evidence="28">
    <location>
      <begin position="1"/>
      <end position="277"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_084046" description="No effect on IFNL1 induction." evidence="24">
    <original>S</original>
    <variation>P</variation>
    <location>
      <position position="134"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_084047" description="No effect on IFNL1 induction; dbSNP:rs780051344." evidence="24">
    <original>R</original>
    <variation>G</variation>
    <location>
      <position position="251"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_052361" description="In dbSNP:rs5743316.">
    <original>N</original>
    <variation>I</variation>
    <location>
      <position position="284"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_052362" description="In dbSNP:rs5743317.">
    <original>Y</original>
    <variation>D</variation>
    <location>
      <position position="307"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_021976" description="In dbSNP:rs3775291." evidence="5 16 18 27">
    <original>L</original>
    <variation>F</variation>
    <location>
      <position position="412"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_054887" description="In IMD83; causes TLR3 deficiency and predisposition to herpes simplex encephalitis; inhibition of IFNL1 induction; dbSNP:rs121434431." evidence="14 24">
    <original>P</original>
    <variation>S</variation>
    <location>
      <position position="554"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_084048" description="No effect on IFNL1 induction; dbSNP:rs988586598 and dbSNP:rs774476397." evidence="24">
    <original>F</original>
    <variation>L</variation>
    <location>
      <position position="732"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_024664" description="In dbSNP:rs5743318.">
    <original>S</original>
    <variation>T</variation>
    <location>
      <position position="737"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_084049" description="Inhibition of IFNL1 induction." evidence="24">
    <location>
      <begin position="746"/>
      <end position="904"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_084050" description="Inhibition of IFNL1 induction." evidence="24">
    <location>
      <begin position="769"/>
      <end position="904"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_084051" description="Inhibition of IFNL1 induction; dbSNP:rs199768900." evidence="24">
    <original>R</original>
    <variation>Q</variation>
    <location>
      <position position="867"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_084052" description="Inhibition of IFNL1 induction." evidence="24">
    <original>M</original>
    <variation>V</variation>
    <location>
      <position position="870"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Reduced response to ds-RNA." evidence="9">
    <original>C</original>
    <variation>A</variation>
    <location>
      <position position="95"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Reduced response to ds-RNA." evidence="9">
    <original>C</original>
    <variation>A</variation>
    <location>
      <position position="122"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Reduced expression levels; when associated with R-247." evidence="9">
    <original>N</original>
    <variation>G</variation>
    <location>
      <position position="196"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Reduced response to ds-RNA. Reduced expression levels; when associated with G-196." evidence="9">
    <original>N</original>
    <variation>R</variation>
    <location>
      <position position="247"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="No effect." evidence="10">
    <original>H</original>
    <variation>A</variation>
    <location>
      <position position="539"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Loss of RNA binding. Constitutive activation of NF-kappa-B." evidence="10">
    <original>H</original>
    <variation>E</variation>
    <location>
      <position position="539"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Loss of RNA binding. Abolishes activation of NF-kappa-B." evidence="10">
    <original>N</original>
    <variation>A</variation>
    <location>
      <position position="541"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Reduced activation of NF-kappa-B in response to ds-RNA. Reduced induction of IL-8 in response to ds-RNA. Loss of interaction with WDFY1." evidence="13 21">
    <original>Y</original>
    <variation>F</variation>
    <location>
      <position position="759"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Loss of ubiquitination by ZNRF1." evidence="26">
    <original>K</original>
    <variation>R</variation>
    <location>
      <position position="812"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Loss of ubiquitination by TRIM3." evidence="23">
    <original>K</original>
    <variation>R</variation>
    <location>
      <position position="831"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Loss of interaction with WDFY1." evidence="21">
    <original>Y</original>
    <variation>F</variation>
    <location>
      <position position="858"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 5; BAG36884." evidence="29" ref="5">
    <original>G</original>
    <variation>R</variation>
    <location>
      <position position="290"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 8; AAH94737." evidence="29" ref="8">
    <original>D</original>
    <variation>N</variation>
    <location>
      <position position="575"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 5; BAG36884." evidence="29" ref="5">
    <original>V</original>
    <variation>A</variation>
    <location>
      <position position="605"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 5; BAG36884." evidence="29" ref="5">
    <original>E</original>
    <variation>G</variation>
    <location>
      <position position="663"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="31"/>
      <end position="36"/>
    </location>
  </feature>
  <feature type="strand" evidence="33">
    <location>
      <begin position="47"/>
      <end position="49"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="54"/>
      <end position="57"/>
    </location>
  </feature>
  <feature type="helix" evidence="32">
    <location>
      <begin position="68"/>
      <end position="74"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="78"/>
      <end position="81"/>
    </location>
  </feature>
  <feature type="helix" evidence="32">
    <location>
      <begin position="94"/>
      <end position="97"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="103"/>
      <end position="105"/>
    </location>
  </feature>
  <feature type="strand" evidence="34">
    <location>
      <begin position="108"/>
      <end position="110"/>
    </location>
  </feature>
  <feature type="turn" evidence="32">
    <location>
      <begin position="118"/>
      <end position="121"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="126"/>
      <end position="129"/>
    </location>
  </feature>
  <feature type="turn" evidence="32">
    <location>
      <begin position="142"/>
      <end position="145"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="151"/>
      <end position="153"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="166"/>
      <end position="168"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="175"/>
      <end position="177"/>
    </location>
  </feature>
  <feature type="helix" evidence="32">
    <location>
      <begin position="188"/>
      <end position="191"/>
    </location>
  </feature>
  <feature type="helix" evidence="32">
    <location>
      <begin position="192"/>
      <end position="194"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="198"/>
      <end position="203"/>
    </location>
  </feature>
  <feature type="helix" evidence="32">
    <location>
      <begin position="216"/>
      <end position="219"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="220"/>
      <end position="223"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="225"/>
      <end position="227"/>
    </location>
  </feature>
  <feature type="helix" evidence="32">
    <location>
      <begin position="234"/>
      <end position="245"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="252"/>
      <end position="254"/>
    </location>
  </feature>
  <feature type="turn" evidence="32">
    <location>
      <begin position="265"/>
      <end position="268"/>
    </location>
  </feature>
  <feature type="helix" evidence="32">
    <location>
      <begin position="269"/>
      <end position="273"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="278"/>
      <end position="280"/>
    </location>
  </feature>
  <feature type="turn" evidence="32">
    <location>
      <begin position="291"/>
      <end position="296"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="302"/>
      <end position="304"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="310"/>
      <end position="313"/>
    </location>
  </feature>
  <feature type="turn" evidence="32">
    <location>
      <begin position="315"/>
      <end position="320"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="326"/>
      <end position="328"/>
    </location>
  </feature>
  <feature type="turn" evidence="36">
    <location>
      <begin position="338"/>
      <end position="340"/>
    </location>
  </feature>
  <feature type="turn" evidence="32">
    <location>
      <begin position="348"/>
      <end position="353"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="359"/>
      <end position="361"/>
    </location>
  </feature>
  <feature type="turn" evidence="32">
    <location>
      <begin position="372"/>
      <end position="377"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="383"/>
      <end position="385"/>
    </location>
  </feature>
  <feature type="strand" evidence="36">
    <location>
      <begin position="390"/>
      <end position="392"/>
    </location>
  </feature>
  <feature type="turn" evidence="32">
    <location>
      <begin position="398"/>
      <end position="401"/>
    </location>
  </feature>
  <feature type="helix" evidence="32">
    <location>
      <begin position="402"/>
      <end position="404"/>
    </location>
  </feature>
  <feature type="strand" evidence="37">
    <location>
      <begin position="405"/>
      <end position="407"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="411"/>
      <end position="413"/>
    </location>
  </feature>
  <feature type="turn" evidence="32">
    <location>
      <begin position="424"/>
      <end position="429"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="435"/>
      <end position="437"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="444"/>
      <end position="446"/>
    </location>
  </feature>
  <feature type="helix" evidence="32">
    <location>
      <begin position="450"/>
      <end position="452"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="460"/>
      <end position="462"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="467"/>
      <end position="470"/>
    </location>
  </feature>
  <feature type="turn" evidence="32">
    <location>
      <begin position="473"/>
      <end position="478"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="484"/>
      <end position="486"/>
    </location>
  </feature>
  <feature type="strand" evidence="37">
    <location>
      <begin position="492"/>
      <end position="494"/>
    </location>
  </feature>
  <feature type="turn" evidence="32">
    <location>
      <begin position="501"/>
      <end position="504"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="510"/>
      <end position="512"/>
    </location>
  </feature>
  <feature type="turn" evidence="32">
    <location>
      <begin position="523"/>
      <end position="528"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="534"/>
      <end position="536"/>
    </location>
  </feature>
  <feature type="helix" evidence="32">
    <location>
      <begin position="543"/>
      <end position="546"/>
    </location>
  </feature>
  <feature type="strand" evidence="35">
    <location>
      <begin position="548"/>
      <end position="550"/>
    </location>
  </feature>
  <feature type="turn" evidence="32">
    <location>
      <begin position="557"/>
      <end position="560"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="566"/>
      <end position="568"/>
    </location>
  </feature>
  <feature type="turn" evidence="32">
    <location>
      <begin position="579"/>
      <end position="584"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="590"/>
      <end position="592"/>
    </location>
  </feature>
  <feature type="turn" evidence="32">
    <location>
      <begin position="603"/>
      <end position="608"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="614"/>
      <end position="616"/>
    </location>
  </feature>
  <feature type="helix" evidence="32">
    <location>
      <begin position="627"/>
      <end position="634"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="638"/>
      <end position="641"/>
    </location>
  </feature>
  <feature type="turn" evidence="36">
    <location>
      <begin position="651"/>
      <end position="653"/>
    </location>
  </feature>
  <feature type="strand" evidence="32">
    <location>
      <begin position="655"/>
      <end position="658"/>
    </location>
  </feature>
  <feature type="helix" evidence="36">
    <location>
      <begin position="671"/>
      <end position="674"/>
    </location>
  </feature>
  <feature type="strand" evidence="36">
    <location>
      <begin position="676"/>
      <end position="680"/>
    </location>
  </feature>
  <feature type="turn" evidence="36">
    <location>
      <begin position="681"/>
      <end position="685"/>
    </location>
  </feature>
  <feature type="helix" evidence="33">
    <location>
      <begin position="688"/>
      <end position="690"/>
    </location>
  </feature>
  <feature type="strand" evidence="35">
    <location>
      <begin position="694"/>
      <end position="696"/>
    </location>
  </feature>
  <feature type="turn" evidence="35">
    <location>
      <begin position="697"/>
      <end position="699"/>
    </location>
  </feature>
  <feature type="helix" evidence="35">
    <location>
      <begin position="702"/>
      <end position="725"/>
    </location>
  </feature>
  <feature type="helix" evidence="38">
    <location>
      <begin position="738"/>
      <end position="745"/>
    </location>
  </feature>
  <evidence type="ECO:0000255" key="1"/>
  <evidence type="ECO:0000255" key="2">
    <source>
      <dbReference type="PROSITE-ProRule" id="PRU00204"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="3">
    <source>
      <dbReference type="PubMed" id="12471095"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="4">
    <source>
      <dbReference type="PubMed" id="12539043"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="5">
    <source>
      <dbReference type="PubMed" id="14702039"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="6">
    <source>
      <dbReference type="PubMed" id="15340161"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="7">
    <source>
      <dbReference type="PubMed" id="15961631"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="8">
    <source>
      <dbReference type="PubMed" id="16043704"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="9">
    <source>
      <dbReference type="PubMed" id="16144834"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="10">
    <source>
      <dbReference type="PubMed" id="16720699"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="11">
    <source>
      <dbReference type="PubMed" id="16858407"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="12">
    <source>
      <dbReference type="PubMed" id="17085778"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="13">
    <source>
      <dbReference type="PubMed" id="17178723"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="14">
    <source>
      <dbReference type="PubMed" id="17872438"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="15">
    <source>
      <dbReference type="PubMed" id="18172197"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="16">
    <source>
      <dbReference type="PubMed" id="18753640"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="17">
    <source>
      <dbReference type="PubMed" id="19159218"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="18">
    <source>
      <dbReference type="PubMed" id="22174453"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="19">
    <source>
      <dbReference type="PubMed" id="22579623"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="20">
    <source>
      <dbReference type="PubMed" id="22611194"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="21">
    <source>
      <dbReference type="PubMed" id="25736436"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="22">
    <source>
      <dbReference type="PubMed" id="31076723"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="23">
    <source>
      <dbReference type="PubMed" id="32878999"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="24">
    <source>
      <dbReference type="PubMed" id="32972995"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="25">
    <source>
      <dbReference type="PubMed" id="33432245"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="26">
    <source>
      <dbReference type="PubMed" id="37158982"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="27">
    <source ref="4"/>
  </evidence>
  <evidence type="ECO:0000303" key="28">
    <source>
      <dbReference type="PubMed" id="14702039"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="29"/>
  <evidence type="ECO:0000312" key="30">
    <source>
      <dbReference type="HGNC" id="HGNC:11849"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="31">
    <source>
      <dbReference type="PDB" id="7C76"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="32">
    <source>
      <dbReference type="PDB" id="1ZIW"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="33">
    <source>
      <dbReference type="PDB" id="2A0Z"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="34">
    <source>
      <dbReference type="PDB" id="5GS0"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="35">
    <source>
      <dbReference type="PDB" id="7C76"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="36">
    <source>
      <dbReference type="PDB" id="7WV3"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="37">
    <source>
      <dbReference type="PDB" id="7WV5"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="38">
    <source>
      <dbReference type="PDB" id="8AR1"/>
    </source>
  </evidence>
  <sequence length="904" mass="103829" checksum="034E05ECA7A4D2F7" modified="1998-01-01" version="1" precursor="true">MRQTLPCIYFWGGLLPFGMLCASSTTKCTVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTSSCKDSAPFELFFMINTSILLIFIFIVLLIHFEGWRISFYWNVSVHRVLGFKEIDRQTEQFEYAAYIIHAYKDKDWVWEHFSSMEKEDQSLKFCLEERDFEAGVFELEAIVNSIKRSRKIIFVITHHLLKDPLCKRFKVHHAVQQAIEQNLDSIILVFLEEIPDYKLNHALCLRRGMFKSHCILNWPVQKERIGAFRHKLQVALGSKNSVH</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>